ICCM (Icecure Medical) Cyclically Adjusted Revenue per Share: $3.86 (As of Mar. 2026)


ICCM Icecure Medical Ltd ICCM
46 GF Score
Price $3.67
GF Value $21.25
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Icecure Medical Cyclically Adjusted Revenue per Share?

Icecure Medical ICCM -5.19% 46 Cyclically Adjusted Revenue per Share is $3.86 as of Mar. 2026. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.25 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Icecure Medical's adjusted revenue per share data for the fiscal year that ended in Dec. 2025 was $1.595. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $3.86 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -24.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Icecure Medical was -24.30% per year. The lowest was -24.30% per year. And the median was -24.30% per year.

As of today (2026-07-11), Icecure Medical's current stock price is $ 3.667. Icecure Medical's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec. 2025 was $3.86. Icecure Medical's Cyclically Adjusted PS Ratio of today is 0.95.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Icecure Medical was 9.50. The lowest was 1.00. And the median was 5.06.


Icecure Medical  (NAS:ICCM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Icecure Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.667/3.86
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Icecure Medical was 9.50. The lowest was 1.00. And the median was 5.06.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Icecure Medical Cyclically Adjusted Revenue per Share Related Terms


Icecure Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Icecure Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icecure Medical Cyclically Adjusted Revenue per Share Chart

Icecure Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 8.91 7.19 4.40 3.86

Icecure Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 3.86 0.00

ICCM vs LFWD, IRIX, GTHP: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Icecure Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Icecure Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Icecure Medical's Cyclically Adjusted PS Ratio falls into.


ICCM
46GF Score
Icecure Medical Ltd ICCM
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Icecure Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Icecure Medical's adjusted Revenue per Share data for the fiscal year that ended in Dec. 2025 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=1.595/324.0540*324.0540
=1.595

Current CPI (Dec. 2025) = 324.0540.

Icecure Medical Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 3.472 241.432 4.660
201712 3.235 246.524 4.252
201812 2.700 251.233 3.483
201912 3.581 256.974 4.516
202012 6.646 260.474 8.268
202112 4.266 278.802 4.958
202212 2.452 296.797 2.677
202312 2.123 306.746 2.243
202412 1.940 315.605 1.992
202512 1.595 324.054 1.595

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $3.86 mean?
Icecure Medical (ICCM) has a Cyclically Adjusted Revenue per Share of $3.86 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Icecure Medical and its competitors.
Is Icecure Medical's Cyclically Adjusted Revenue per Share too high?
Icecure Medical's current Cyclically Adjusted Revenue per Share is $3.86. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's Cyclically Adjusted Revenue per Share compare to LFWD and IRIX?
Icecure Medical's Cyclically Adjusted Revenue per Share of $3.86 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Icecure Medical and its competitors. Icecure Medical's current Cyclically Adjusted Revenue per Share is $3.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.25, compared to a current price of $3.67 — trading 82.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $3.86. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Icecure Medical (ICCM), the current Cyclically Adjusted Revenue per Share is $3.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icecure Medical (ICCM) Overvalued in 2026?

Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued. The current stock price of $3.67 is trading 82.7% below its estimated GF Value™ of $21.25. GuruFocus considers Icecure Medical to be Possible Value Trap.

Key valuation signals for ICCM:

  • Cyclically Adjusted Revenue per Share: $3.86
  • GF Value™: $21.25 vs. price of $3.67 (82.7% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Icecure Medical Business Description

Address 7 Haeshel Street, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score

Get the complete analysis for ICCM

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.67
Price
$21.25
GF Value